| scholarly article | Q13442814 |
| P356 | DOI | 10.1084/JEM.188.9.1763 |
| P8608 | Fatcat ID | release_ths5ylqm65bczn3joxpxb2azte |
| P932 | PMC publication ID | 2212516 |
| P698 | PubMed publication ID | 9802988 |
| P5875 | ResearchGate publication ID | 13483509 |
| P50 | author | Antonio Costanzo | Q38319077 |
| Alessandro Terrinoni | Q42836714 | ||
| Vincenzo De Laurenzi | Q46755072 | ||
| Massimo Levrero | Q67592879 | ||
| P2093 | author name string | G Melino | |
| M Falco | |||
| M Annicchiarico-Petruzzelli | |||
| D Barcaroli | |||
| P2860 | cites work | Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins | Q24311703 |
| Synergistic activation of transcription by CBP and p53 | Q24311979 | ||
| Binding and modulation of p53 by p300/CBP coactivators | Q24312018 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Recruitment of p300/CBP in p53-dependent signal pathways | Q28243213 | ||
| Mutations in the p53 gene occur in diverse human tumour types | Q28249770 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product | Q28645822 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 | ||
| Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers | Q29616471 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| p53: oncogene or anti-oncogene? | Q34627381 | ||
| The hepatitis B virus X gene induces p53-mediated programmed cell death | Q36303449 | ||
| Chromosomal aberrations in human neuroblastomas | Q41057218 | ||
| Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stre | Q41087172 | ||
| p73 is a simian [correction of human] p53-related protein that can induce apoptosis | Q41091013 | ||
| P53 associates with trk tyrosine kinase | Q41099207 | ||
| Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif | Q41555610 | ||
| Lonely no more: p53 finds its kin in a tumor suppressor haven | Q41595266 | ||
| Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma | Q48030109 | ||
| Transcriptional activation by p53 correlates with suppression of growth but not transformation. | Q53468212 | ||
| Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. | Q53505779 | ||
| Cytogenetic studies in primary and metastatic neuroendocrine merkel cell carcinoma | Q58813595 | ||
| Killer in search of a motive? | Q58987146 | ||
| Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers | Q74427906 | ||
| Apoptosis and the cell cycle: the p53 connection | Q77315452 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1763-1768 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Two new p73 splice variants, gamma and delta, with different transcriptional activity | |
| P478 | volume | 188 |
| Q36623189 | A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma |
| Q28118809 | A common polymorphism acts as an intragenic modifier of mutant p53 behaviour |
| Q36898974 | A gene signature-based approach identifies mTOR as a regulator of p73. |
| Q51660356 | A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function. |
| Q40228726 | A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells |
| Q34218441 | A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity |
| Q39458140 | A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain |
| Q37216001 | Aberrant cytoplasmic expression of p63 and prostate cancer mortality |
| Q44495330 | Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells |
| Q38247152 | Alterations of p63 and p73 in human cancers |
| Q30167715 | Amphiphysin IIb-1, a novel splicing variant of amphiphysin II, regulates p73beta function through protein-protein interactions |
| Q80601828 | Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia |
| Q39662010 | Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines |
| Q36994773 | Analysis of the oligomeric state and transactivation potential of TAp73α. |
| Q38289031 | Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage |
| Q34277205 | Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter |
| Q33838181 | BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD). |
| Q73898479 | Binding of the C-terminal sterile alpha motif (SAM) domain of human p73 to lipid membranes |
| Q24323081 | Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription |
| Q40014129 | C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity |
| Q33551236 | C-terminal ubiquitination of p53 contributes to nuclear export |
| Q36907168 | Caspase-1 is a novel target of p63 in tumor suppression |
| Q34141459 | Cell cycle and cell fate in the nervous system. |
| Q35867909 | Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression |
| Q73646221 | Characterization of p73 functional domains necessary for transactivation and growth suppression |
| Q24317558 | Cloning and characterization of human and mouse DDA3 genes |
| Q35604588 | Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons |
| Q27657467 | Conformational stability and activity of p73 require a second helix in the tetramerization domain |
| Q28144708 | Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif |
| Q39565566 | Crosstalk between c-Jun and TAp73alpha/beta contributes to the apoptosis-survival balance |
| Q40658272 | Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73. |
| Q40729390 | DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. |
| Q26775866 | DNA repair and aging: the impact of the p53 family |
| Q42163174 | DeltaN-p73alpha accumulates in human neuroblastic tumors |
| Q40581726 | DeltaNp73beta is active in transactivation and growth suppression. |
| Q73800193 | Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status |
| Q79768076 | Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia |
| Q40474411 | Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain. |
| Q73876731 | Differential regulation of p63 and p73 expression |
| Q38317198 | Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding |
| Q38317803 | E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. |
| Q36643752 | E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia |
| Q28077156 | Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness |
| Q28074586 | Epstein-Barr Virus: Diseases Linked to Infection and Transformation |
| Q43583398 | Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer |
| Q42412666 | Expression of p53 isoforms in squamous cell carcinoma of the head and neck |
| Q73120645 | Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes |
| Q24310627 | FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription |
| Q40366104 | Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription |
| Q34164614 | From p63 to p53 across p73. |
| Q30936349 | Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. |
| Q24633799 | Functional association between Wwox tumor suppressor protein and p73, a p53 homolog |
| Q74108637 | Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer |
| Q45744096 | Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein |
| Q28910323 | Functional interplay between MDM2, p63/p73 and mutant p53 |
| Q38099613 | Functions, divergence and clinical value of TAp73 isoforms in cancer. |
| Q34813092 | Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients. |
| Q78484469 | Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites |
| Q35216158 | Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells |
| Q40015300 | HtrA2 enhances the apoptotic functions of p73 on bax. |
| Q36394792 | Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation. |
| Q43560180 | Human T-cell leukemia virus type I tax repression of p73beta is mediated through competition for the C/H1 domain of CBP. |
| Q53393697 | Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. |
| Q38363282 | Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. |
| Q40455860 | Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function. |
| Q44124982 | Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73. |
| Q79696856 | Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death |
| Q48308845 | Induction of apoptosis by the p53-related p73 and partial inhibition by the baculovirus-encoded p35 in neuronal cells |
| Q40880106 | Induction of neuronal differentiation by p73 in a neuroblastoma cell line |
| Q24531472 | Induction of p57(KIP2) expression by p73beta. |
| Q33725939 | Interactions of the p53 protein family in cellular stress response in gastrointestinal tumors |
| Q36604805 | Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors |
| Q34671614 | Iron chelators as therapeutic agents for the treatment of cancer. |
| Q35250114 | Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines |
| Q45038997 | Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers |
| Q73835852 | Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation |
| Q58327595 | MDM2 and MDMX can interact differently with ARF and members of the p53 family |
| Q28141357 | Mdm2 binds p73 alpha without targeting degradation |
| Q45345758 | Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function |
| Q24804223 | Measuring a cell's response to stress: the p53 pathway |
| Q27728187 | Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization |
| Q42626865 | Molecular characterization of the first non-mammalian p73 cDNA. |
| Q47982598 | Molecular clock and gene function |
| Q57045501 | Molecular strategies in Metazoan genomic evolution |
| Q42813449 | Mouse DDA3 gene is a direct transcriptional target of p53 and p73. |
| Q34928405 | Multiple stress signals induce p73beta accumulation |
| Q35250103 | Mutation and expression of the p51 gene in human lung cancer |
| Q46273393 | Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism |
| Q40690754 | Novel cell-specific and dominant negative anti-apoptotic roles of p73 in transformed leukemia cells |
| Q26781297 | Novel endogenous angiogenesis inhibitors and their therapeutic potential |
| Q34511214 | On the shoulders of giants: p63, p73 and the rise of p53. |
| Q42575797 | Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme |
| Q26749382 | Oncogenic Intra-p53 Family Member Interactions in Human Cancers |
| Q33290650 | Overexpressed TP73 induces apoptosis in medulloblastoma |
| Q52934103 | Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. |
| Q38882601 | Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines |
| Q42513771 | Overproduced p73alpha activates a minimal promoter through a mechanism independent of its transcriptional activity |
| Q34185768 | P63 and P73: P53 mimics, menaces and more |
| Q36736367 | P73 and age-related diseases: is there any link with Parkinson Disease? |
| Q39999072 | P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis |
| Q42509601 | P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? |
| Q40616826 | PCAF is a coactivator for p73-mediated transactivation |
| Q24559766 | PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73 |
| Q58073315 | Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73 |
| Q24301094 | Physical and functional interaction between HCV core protein and the different p73 isoforms |
| Q52169566 | Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions. |
| Q34114100 | Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function |
| Q24529877 | Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression |
| Q24291023 | Physical interaction with Yes-associated protein enhances p73 transcriptional activity |
| Q38291171 | Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. |
| Q36288249 | Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma |
| Q39892741 | Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain |
| Q43771754 | Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis |
| Q35103149 | Regulation of Fertility by the p53 Family Members |
| Q35865249 | Regulation of p73 activity by post-translational modifications |
| Q40045967 | RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells. |
| Q41920691 | Relative expression of TAp73 and ΔNp73 isoforms |
| Q38330053 | Relief of p53-mediated telomerase suppression by p73. |
| Q40848736 | Role for the p53 homologue p73 in E2F-1-induced apoptosis |
| Q33810088 | Role of p53 family members in apoptosis |
| Q34541091 | Role of p73 in malignancy: tumor suppressor or oncogene? |
| Q42483377 | Role of p73 in regulating human caspase-1 gene transcription induced by interferon-{gamma} and cisplatin |
| Q38306110 | Role of the p53-homologue p73 in E2F1-induced apoptosis |
| Q52027067 | S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. |
| Q38072351 | Senescence regulation by the p53 protein family |
| Q38343516 | Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer |
| Q42526350 | Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin |
| Q33787611 | Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene |
| Q36496801 | Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin |
| Q27646113 | Structural evolution of C-terminal domains in the p53 family |
| Q35947662 | TAp63γ enhances nucleotide excision repair through transcriptional regulation of DNA repair genes |
| Q37071124 | TAp73 enhances the pentose phosphate pathway and supports cell proliferation |
| Q34624156 | TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis |
| Q40213854 | TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones. |
| Q36919913 | TAp73 knockout shows genomic instability with infertility and tumor suppressor functions |
| Q38320453 | TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. |
| Q39421785 | TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death |
| Q28579894 | TNF-alpha-mediated apoptosis in vascular smooth muscle cells requires p73 |
| Q35078717 | TP53 family members and human cancers |
| Q33358710 | TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy |
| Q37100742 | Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling |
| Q39871640 | The BAG-1 cochaperone is a negative regulator of p73-dependent transcription |
| Q40446389 | The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73. |
| Q24311644 | The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73 |
| Q24314498 | The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch |
| Q33593937 | The emerging p53 gene family |
| Q38289606 | The human p73 promoter: characterization and identification of functional E2F binding sites |
| Q36521923 | The p53 family in nervous system development and disease |
| Q33720564 | The p53 family: same response, different signals? |
| Q33807839 | The p53 gene family |
| Q34187832 | The p53 tumour suppressor protein |
| Q36422865 | The role of p73 in hematological malignancies |
| Q24746257 | The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation |
| Q77672293 | The two faces of p73 |
| Q22010200 | The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage |
| Q24293071 | The ubiquitin-protein ligase Itch regulates p73 stability |
| Q36979908 | Therapeutic prospects for p73 and p63: rising from the shadow of p53. |
| Q36556362 | Tissue-specific expression of p73 C-terminal isoforms in mice. |
| Q34100529 | Tracing the protectors path from the germ line to the genome |
| Q40810992 | Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. |
| Q38325797 | Transactivation-dependent and -independent regulation of p73 stability |
| Q36673695 | Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. |
| Q38300240 | Transcriptional activities of p73 splicing variants are regulated by inter-variant association. |
| Q55011897 | Transcriptional deregulation underlying the pathogenesis of small cell lung cancer. |
| Q28364211 | Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51 |
| Q38290743 | Transcriptional inactivation of TP73 expression in oligodendroglial tumors |
| Q34334443 | Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer |
| Q38298822 | Tumor necrosis factor-alpha-induced caspase-1 gene expression. Role of p73. |
| Q40371709 | UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination |
| Q35082705 | Ubiquitin and ubiquitin-like modifications of the p53 family |
| Q36399088 | Ubiquitin-dependent degradation of p73 is inhibited by PML. |
| Q57044029 | VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX |
| Q38304778 | ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes |
| Q47807561 | c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association |
| Q40527005 | c-Jun regulates the stability and activity of the p53 homologue, p73. |
| Q52044852 | deltaEF1 repressor controls selectively p53 family members during differentiation. |
| Q35641380 | microRNA-34a regulates neurite outgrowth, spinal morphology, and function |
| Q41685839 | p53 Family members p63 and p73 are SAM domain-containing proteins |
| Q36052576 | p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes |
| Q34405292 | p53 inactivation upregulates p73 expression through E2F-1 mediated transcription |
| Q40720232 | p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop |
| Q44426545 | p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis |
| Q35635329 | p53 protein variants: structural and functional similarities with p63 and p73 isoforms |
| Q34515770 | p53, p63 and p73--solos, alliances and feuds among family members |
| Q89805472 | p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality? |
| Q74083357 | p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53 |
| Q36846083 | p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo |
| Q36443527 | p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. |
| Q31109129 | p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data |
| Q36749787 | p63 and p73 in human cancer: defining the network |
| Q34080237 | p63 and p73, the ancestors of p53. |
| Q30595453 | p63 and p73: old members of a new family |
| Q35192806 | p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation |
| Q36581663 | p63 the guardian of human reproduction |
| Q37983307 | p63/p73 in the control of cell cycle and cell death. |
| Q43652191 | p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes |
| Q55322510 | p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms. |
| Q40614201 | p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation |
| Q28206369 | p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression |
| Q28590574 | p73 and p63 protein stability: the way to regulate function? |
| Q28611414 | p73 as a pharmaceutical target for cancer therapy |
| Q43700522 | p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner |
| Q53625386 | p73 cooperates with Ras in the activation of MAP kinase signaling cascade. |
| Q52671036 | p73 coordinates with Δ133p53 to promote DNA double-strand break repair. |
| Q40774641 | p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque |
| Q28364918 | p73 is over-expressed in vulval cancer principally as the Delta 2 isoform |
| Q52101616 | p73 is regulated by phosphorylation at the G2/M transition. |
| Q73787650 | p73 is transcriptionally regulated by DNA damage, p53, and p73 |
| Q42575247 | p73 plays a role in erythroid differentiation through GATA1 induction. |
| Q40170381 | p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death |
| Q37163723 | p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. |
| Q64951157 | p73 regulates epidermal wound healing and induced keratinocyte programming. |
| Q40896738 | p73 transcriptional activity increases upon cooperation between its spliced forms |
| Q36306728 | p73, a sophisticated p53 family member in the cancer world |
| Q34307362 | p73, the "assistant" guardian of the genome? |
| Q38731186 | p73-Binding Partners and Their Functional Significance |
| Q44872954 | p73-alpha is capable of inducing scotin and ER stress |
| Q28513003 | p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours |
| Q34770297 | p73: Friend or foe in tumorigenesis |
| Q34709625 | p73: a multifunctional protein in neurobiology |
| Q34023178 | p73: structure and function |
| Q40709921 | pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation |
| Q60301981 | polymorphism and cancer susceptibility: evidence from 36 case-control studies |
| Q34510516 | ΔNp73 enhances promoter activity of TGF-β induced genes |
Search more.